One Step Forward In AMR

May 19-21, 2026 | Ames, IA

NIAMRRE is excited to be holding our sixth annual conference, hosted by Food Forward and Iowa State University. Bringing together professionals within academia, industry, and government from across the One Health spectrum (plants, animals, humans, and the environment), we will work together in taking “One Step Forward: Mobilizing Collaboration, Innovation, and Action Against AMR”

With a mix of presentations, panels, facilitated discussions, workshops, and informal gatherings, you will leave this conference with new connections and actionable steps we can take together to combat antimicrobial resistance. 

Register Now & Save!

Gateway Hotel & Conference Center | Ames, IA

The NIAMRRE 2026 Annual Conference will be held at the Gateway Hotel & Conference Center in Ames, Iowa

• Within minutes of the ISU Research Park and ISU Campus
• 50-60 minute drive from Des Moines International Airport
• Onsite Restaurant

Susan Winckler, RPh, Esq., is CEO of the Reagan-Udall Foundation for the Food and Drug Administration. The Foundation is the non-profit organization created by Congress to advance the mission of the FDA. Prior to accepting the Foundation post in May of 2020, Ms. Winckler served as President of Leavitt Partners Solutions. As President and Chief Risk Management Officer for the Leavitt Partners family of businesses, Ms. Winckler advised corporate executives on policy and business matters. As CEO of the Food & Drug Law Institute, she provided attorneys, regulators, industry leaders, and consumers with a neutral forum to address domestic and global issues.

As FDA Chief of Staff from 2007-2009, Ms. Winckler managed the Commissioner’s office; served as his/her senior staff adviser; analyzed policies; and represented FDA before myriad government and external stakeholders. She simultaneously led FDA’s Offices of Legislation, External Relations, Public Affairs, and Executive Secretariat.

As APhA Vice President Policy/Communications and Staff Counsel, she served as the association’s lead spokesperson and senior liaison to Congress, the executive branch, state associations, and allied groups. Ms. Winckler earned a BS from the University of Iowa College of Pharmacy and her JD magna cum laude from Georgetown University Law Center. She is an APhA Fellow, an elected member and Chair of the United States Pharmacopeial Convention (USP) Board of Trustees (2015-2020, 2020-2025), a member of the Purgo Scientific, LLC board, and a member of the Virginia Commonwealth University School of Pharmacy National Advisory Council.

Dr. Julia Szymczak, PhD is an Associate Professor in the Division of Epidemiology at the University of Utah School of Medicine, where she Co-Directs the Utah Quality Advancement Laboratory (UQuAL). Dr. Szymczak is a medical sociologist who leads research that integrates social science theory and methods into efforts to transform healthcare delivery so it is reliably safe, equitable, and high quality. Her work over the past eight years has focused on reducing the harm to patients and populations from antibiotic-resistant bacteria with the following objectives: 1) characterize the social determinants of antibiotics across clinical contexts, 2) generate evidence about what works to improve how antibiotics are prescribed, and 3) advance the use of implementation science in antibiotic stewardship research.

Dr. Christina Sarubbi is the Manager of Clinical Services at UNC Health Rex. Dr. Sarubbi earned her undergraduate and pharmacy degrees from the University of North Carolina at Chapel Hill and also completed her MBA from the UNC Kenan-Flagler Business School. She completed her pharmacy residency at the University of California, San Diego Health System. Since completing her residency, Dr. Sarubbi worked as an Antibiotic Stewardship pharmacist at Duke University Hospital prior to joining UNC in late 2019.  While at Duke, she contributed to research involving the evaluation of a pharmacist-led penicillin allergy assessment program as well as the influence of a reported penicillin allergy on mortality in methicillin-susceptible Staphylococcus aureus bacteremia. Her professional interests include medication safety, quality improvement, and Antibiotic Stewardship. Dr. Sarubbi continues to serve as an active member of the Rex Antibiotic Stewardship team and completes penicillin allergy assessments and de-labeling regularly.